ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2019
Cardiac cachexia.
Article in European heart journal supplements : journal of the European Society of Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 38 citations in OpenAlex.
- Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced.European journal of heart failure · 2023Trial
- Trial
- When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning.Fundamental & clinical pharmacology · 2026Review
- Machine learning-based early identification of heart failure/congestion complicating acute coronary syndrome using body composition analysis: a retrospective cohort study.Frontiers in cardiovascular medicine · 2026Article
- Total body water to lean body mass ratio predicts mortality in patients with chronic heart failure: a prospective, observational study.Frontiers in nutrition · 2026Article
- Circulating miRNAs Signature as a Predictor of Cachexia in Chronic Heart Failure: Diagnostic and Prognostic Implications.Journal of cardiovascular translational research · 2025Article
- Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer.European journal of heart failure · 2025Article
- GLP-1 Receptor Agonists in Heart Failure.Biomolecules · 2025Review
- Identification of Candidate Inflammatory-Nutritional Blood Biomarkers for Cachexia and Muscle Depletion in Polish Chronic Heart Failure Patients.Journal of cardiovascular translational research · 2025Article
- Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC.European journal of heart failure · 2025Article
- Beyond the Scale: The Hidden Burden of Underweight and Cachexia in Adults with Congenital Heart Defects and Heart Failure-Results from the Pathfinder CHD-Registry.Journal of clinical medicine · 2025Article
- Weight Gain Among Cancer Patients Receiving Chemotherapy-Facts and Numbers.Journal of cachexia, sarcopenia and muscle · 2025Article
- Impact of semaglutide on weight and functional outcomes among obese heart failure patients: a propensity scores matching analysis.BMC cardiovascular disorders · 2024Article
- Cancer cachexia: biomarkers and the influence of age.Molecular oncology · 2024Review
- A Narrative Review of the Diagnosis and Treatment of Sarcopenia and Malnutrition in Patients with Heart Failure.Nutrients · 2024Review
- The left ventricular assist device 'skeleton man': case report-simple tools for skeletal muscle evaluation and very early aerobic/resistance/inspiratory training in cardiac cachexia.European heart journal. Case reports · 2024Article
- Experience and the nutritional relevance of protein-enriched ice cream in patients with heart failure - A pilot study.Heliyon · 2024Article
- Exercise training outcomes in patients with chronic heart failure with reduced ejection fraction depend on patient background.Frontiers in cardiovascular medicine · 2024Article
- Premorbid weight in pulmonary arterial hypertension.Pulmonary circulation · 2023Article
- Progressive development of melanoma-induced cachexia differentially impacts organ systems in mice.Cell reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cachexia is a multifactorial disease characterized by a pathologic shift of metabolism towards a more catabolic state. It frequently occurs in patients with chronic diseases such as chronic heart failure and is especially common in the elderly. In patients at risk, cardiac cachexia is found in about 10% of heart failure patients. The negative impact of cardiac cachexia on mortality, morbidity, and quality of life demonstrates the urgent need to find new effective therapies against cardiac cachexia. Furthermore, exercise training and nutritional support can help patients with cardiac cachexia. Despite ongoing efforts to find new therapies for cachexia treatment, also new preventive strategies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.